Kath Watson

8.0k total citations · 2 hit papers
79 papers, 5.8k citations indexed

About

Kath Watson is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Kath Watson has authored 79 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Rheumatology, 20 papers in Immunology and 18 papers in Genetics. Recurrent topics in Kath Watson's work include Rheumatoid Arthritis Research and Therapies (60 papers), Systemic Lupus Erythematosus Research (26 papers) and Chronic Lymphocytic Leukemia Research (18 papers). Kath Watson is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (60 papers), Systemic Lupus Erythematosus Research (26 papers) and Chronic Lymphocytic Leukemia Research (18 papers). Kath Watson collaborates with scholars based in United Kingdom, Norway and Australia. Kath Watson's co-authors include Deborah Symmons, Kimme L Hyrich, Mark Lunt, William G Dixon, Alan J. Silman, James Galloway, Andrew Ustianowski, Louise Mercer, Darren M. Ashcroft and Gary J. Macfarlane and has published in prestigious journals such as The Lancet, PEDIATRICS and Pain.

In The Last Decade

Kath Watson

77 papers receiving 5.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

2009 532 citations William G Dixon, Kimme L Hyrich et al. Annals of the Rheumatic Diseases profile →
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

2010 496 citations James Galloway, Kimme L Hyrich et al. Lara D. Veeken profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Kath Watson	3.6k	1.6k	1.4k	723	636	79	5.8k
Sjef van der Linden	9.9k 2.7×	3.7k 2.3×	2.9k 2.0×	414 0.6×	966 1.5×	66	11.8k
Sofía Ramiro	5.5k 1.5×	2.5k 1.6×	1.6k 1.1×	594 0.8×	493 0.8×	281	7.5k
Atul Deodhar	6.8k 1.9×	5.0k 3.1×	2.8k 2.0×	322 0.4×	559 0.9×	307	9.1k
Mario H. Cardiel	3.3k 0.9×	1.7k 1.1×	787 0.5×	255 0.4×	466 0.7×	121	4.7k
Carter Thorne	2.9k 0.8×	963 0.6×	1.1k 0.8×	451 0.6×	519 0.8×	172	4.5k
Carol A. Wallace	1.9k 0.5×	1.1k 0.7×	4.6k 3.2×	281 0.4×	359 0.6×	99	6.6k
Timo Möttönen	2.7k 0.7×	463 0.3×	1.1k 0.7×	503 0.7×	956 1.5×	114	4.6k
Ori Elkayam	2.1k 0.6×	1.6k 1.0×	840 0.6×	160 0.2×	319 0.5×	155	4.5k
Johanna M W Hazes	2.8k 0.8×	608 0.4×	1.0k 0.7×	437 0.6×	416 0.7×	80	3.7k
Liron Caplan	2.7k 0.8×	749 0.5×	797 0.6×	408 0.6×	640 1.0×	100	4.5k

Countries citing papers authored by Kath Watson

Since Specialization

Citations

This map shows the geographic impact of Kath Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kath Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kath Watson more than expected).

Fields of papers citing papers by Kath Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kath Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kath Watson. The network helps show where Kath Watson may publish in the future.

Co-authorship network of co-authors of Kath Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Kath Watson. A scholar is included among the top collaborators of Kath Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kath Watson. Kath Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kearsley‐Fleet, Lianne, et al.. (2024). Potential impact of European Medicines Agency measures to minimize risk of serious side effects on JAKi prescribing and utilization in the UK. Lara D. Veeken. 64(3). 1453–1458. 1 indexed citations

Tsoi, Man Fung, et al.. (2024). Association between body weight and tocilizumab effectiveness in rheumatoid arthritis: results from the BSRBR-RA. Lara D. Veeken. 64(2). 477–483. 1 indexed citations

Lauper, Kim, Lianne Kearsley‐Fleet, James Galloway, et al.. (2023). Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying anti-rheumatic drugs: does line of therapy matter?. Lara D. Veeken. 63(7). 1957–1964. 4 indexed citations

Zhao, Sizheng Steven, Lianne Kearsley‐Fleet, Kath Watson, et al.. (2023). P144 Socioeconomic deprivation is associated with reduced response and lower treatment persistence with anti-TNF therapies in people with rheumatoid arthritis. Lara D. Veeken. 62(Supplement_2). 1 indexed citations

Kearsley‐Fleet, Lianne, Kim Lauper, Kath Watson, et al.. (2023). OA01 No difference in risk of myocardial infarction among patients receiving either IL6 or TNF inhibitors for rheumatoid arthritis. Lara D. Veeken. 62(Supplement_2). 1 indexed citations

Jani, Meghna, William G Dixon, Lianne Kearsley‐Fleet, et al.. (2017). Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA. RMD Open. 3(1). e000314–e000314. 26 indexed citations

Cock, Diederik De, Kath Watson, & Kimme L Hyrich. (2017). 228. BIOSIMILARS IN THE UNITED KINGDOM: FIRST REAL-WORLD DATA FROM THE BRITISH SOCIETY FOR RHEUMATOLOGY BIOLOGICS REGISTERS FOR RHEUMATOID ARTHRITIS. Lara D. Veeken. 56(suppl_2). 3 indexed citations

Kearsley‐Fleet, Lianne, Flora McErlane, Helen Foster, et al.. (2016). Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritis. RMD Open. 2(2). e000273–e000273. 7 indexed citations

Mercer, Louise, Adèle C. Green, James Galloway, et al.. (2012). The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register. Annals of the Rheumatic Diseases. 71(6). 869–874. 95 indexed citations

10.

Soliman, Moetaza M., Kimme L Hyrich, Mark Lunt, et al.. (2012). Rituximab or a second anti–tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti–tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register. Arthritis Care & Research. 64(8). 1108–1115. 63 indexed citations

11.

Verstappen, Suzanne, et al.. (2010). Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register. Lara D. Veeken. 49(8). 1570–1577. 70 indexed citations

12.

Lunt, Mark, et al.. (2010). No evidence of association between anti–tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register. Arthritis & Rheumatism. 62(11). 3145–3153. 68 indexed citations

13.

Dixon, William G, Kath Watson, Mark Lunt, et al.. (2010). Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register. Arthritis Care & Research. 62(6). 755–763. 152 indexed citations

14.

Dixon, William G, Kath Watson, Mark Lunt, et al.. (2007). Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register. Arthritis & Rheumatism. 56(9). 2905–2912. 429 indexed citations

15.

Dixon, William G, Deborah Symmons, Mark Lunt, et al.. (2007). Serious infection following anti–tumor necrosis factor α therapy in patients with rheumatoid arthritis: Lessons from interpreting data from observational studies. Arthritis & Rheumatism. 56(9). 2896–2904. 219 indexed citations

16.

Watson, Kath, William G Dixon, Kimme L Hyrich, et al.. (2006). Influence of anti-TNF therapy and previous malignancy on cancer incidence in patients with rheumatoid arthritis (RA): Results from the BSR biologics register. Annals of the Rheumatic Diseases. 65. 512–512. 18 indexed citations

17.

Watson, Kath, William G Dixon, Kimme L Hyrich, et al.. (2006). Influence of anti-tnf therapy and previous malignancy on cancer incidence in patients with Rheumatoid Arthritis (RA): Results from the BSR biologics register (BSRBR). Lara D. Veeken. 45. 11 indexed citations

18.

Watson, Kath, et al.. (2005). All cause mortality is not increased following the use of anti-TNF agents in patients with rheumatoid arthritis: Results from a nationwide prospective study. Arthritis & Rheumatism. 52. 1 indexed citations

19.

Watson, Kath, et al.. (2005). Anti-TNF therapy and mortality in rheumatoid arthritis patients registered with the British Society for Rheumatology Biologics Register (BSRBR). Annals of the Rheumatic Diseases. 64. 12 indexed citations

20.

Watson, Kath, A C Papageorgiou, Gregory T. Jones, et al.. (2003). Low back pain in schoolchildren: Ocurrence and characteristics. Revista de la Sociedad Española del Dolor. 10. 203–210. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact